MarketPeel
Insider Trading Intelligence
Pricing
…
RB

Richard Barry

SRPT
DIRECTOR · SAREPTA THERAPEUTICS, INC. · CIK 0001562371
FILING MIX · LIFETIME83%/17%
BUYS
38
SELLS
8
TOTAL VALUE
$22.79M
COMPANIES
3
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
7,259,737
AVG SELL PX
$149.88
TRADE KIND
SHOWING 46 / 46
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
13 backtested trades · 8 horizons · 14 pending
Forward-return performance of every backtestable P/S trade by Richard Barry, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d13+84.62%+18.08%+1.15%+16.93%+20.70%—
14d13+84.62%+24.48%+2.73%+21.74%+9.52%—
30d13+69.23%+30.40%+3.04%+27.36%+5.33%—
60d13+69.23%+9.18%+3.86%+5.33%+14.16%—
90d13+69.23%+13.93%+6.93%+7.00%-0.11%—
180d13+54.55%-3.45%+10.63%-13.67%-15.89%—
1y13(7 pending)+100.00%-12.64%+38.40%-51.04%-84.02%—
2y13(7 pending)+66.67%-50.24%+43.76%-94.00%-96.06%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
SRPT · 2,983,542 shares · as of Jun 4, 2026
0797,2851,594,5702,391,8553,189,140202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 38 buys / 8 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
16,875——2,983,542Jun 4, 2026Jun 5, 2026 ↗View →
SAVA
FILANA THERAPEUTICS, INC.
PURCHASE
President & CEO
150,000$2.76$414.0K938,060Nov 20, 2025Nov 24, 2025 ↗View →
SAVA
FILANA THERAPEUTICS, INC.
PURCHASE
President & CEO
73,385$2.75$201.8K788,060Nov 19, 2025Nov 20, 2025 ↗View →
SAVA
FILANA THERAPEUTICS, INC.
PURCHASE
President & CEO
7,172$2.28$16.4K714,675Sep 22, 2025Sep 23, 2025 ↗View →
SAVA
FILANA THERAPEUTICS, INC.
PURCHASE
President & CEO
400$2.25$900660,595Sep 19, 2025Sep 22, 2025 ↗View →
SAVA
FILANA THERAPEUTICS, INC.
PURCHASE
President & CEO
46,908$2.29$107.4K707,503Sep 19, 2025Sep 22, 2025 ↗View →
SAVA
FILANA THERAPEUTICS, INC.
PURCHASE
President & CEO
5,400$2.13$11.5K474,962Sep 18, 2025Sep 22, 2025 ↗View →
SAVA
FILANA THERAPEUTICS, INC.
PURCHASE
President & CEO
185,233$2.24$414.9K660,195Sep 18, 2025Sep 22, 2025 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
SALE
12,350——0May 16, 2025May 19, 2025 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASE
12,350$32.63$403.0K2,966,667May 16, 2025May 19, 2025 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
SALE
10,500——0May 13, 2025May 15, 2025 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASE
10,500$13.71$144.0K2,954,317May 13, 2025May 15, 2025 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASE
9,746$25.18$245.4K2,943,817May 13, 2025May 15, 2025 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
SALE
9,746——0May 13, 2025May 15, 2025 ↗View →
SAVA
FILANA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
350,000——350,000Apr 17, 2025Apr 21, 2025 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
4,792——4,792Mar 10, 2025Mar 11, 2025 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
2,383——2,934,071Mar 10, 2025Mar 11, 2025 ↗View →
SAVA
FILANA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
600,000——600,000Oct 1, 2024Oct 1, 2024 ↗View →
SAVA
FILANA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
15,000——15,000May 9, 2024May 13, 2024 ↗View →
SAVA
FILANA THERAPEUTICS, INC.
PURCHASE
176,085$22.00$3.87M469,562Apr 23, 2024Apr 25, 2024 ↗View →
SAVA
FILANA THERAPEUTICS, INC.
SALE
117,390——0Apr 23, 2024Apr 25, 2024 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
1,846——2,931,688Mar 1, 2024Mar 5, 2024 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
3,679——3,679Mar 1, 2024Mar 5, 2024 ↗View →
SAVA
FILANA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
117,390——176,085Jan 3, 2024Apr 25, 2024 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASE
10,000$78.81$788.1K10,000Nov 3, 2023Nov 6, 2023 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASE
40,000$78.81$3.15M140,000Nov 3, 2023Nov 6, 2023 ↗View →
SAVA
FILANA THERAPEUTICS, INC.
PURCHASE
16,571$16.65$275.9K293,477Aug 22, 2023Aug 23, 2023 ↗View →
SAVA
FILANA THERAPEUTICS, INC.
PURCHASE
1,906$16.80$32.0K276,906Aug 21, 2023Aug 23, 2023 ↗View →
SAVA
FILANA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,000$22.34$111.7K5,000May 4, 2023May 8, 2023 ↗View →
SAVA
FILANA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
20,000$22.34$446.8K25,000May 4, 2023May 8, 2023 ↗View →
SAVA
FILANA THERAPEUTICS, INC.
PURCHASE
77,276$25.76$1.99M275,000Mar 7, 2023Mar 8, 2023 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
3,257——3,257Mar 6, 2023Mar 8, 2023 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
1,523——2,929,842Mar 6, 2023Mar 8, 2023 ↗View →
SAVA
FILANA THERAPEUTICS, INC.
PURCHASE
11,565$26.13$302.2K197,724Mar 6, 2023Mar 8, 2023 ↗View →
SAVA
FILANA THERAPEUTICS, INC.
PURCHASE
36,159$23.79$860.2K186,159Aug 23, 2022Aug 25, 2022 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,077——5,077Mar 7, 2022Mar 8, 2022 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
2,953——2,928,319Mar 7, 2022Mar 8, 2022 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
2,726——3,125,366Mar 3, 2021Mar 5, 2021 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,518——5,518Mar 3, 2021Mar 5, 2021 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
SALE
3,140$159.09$499.5K3,129,140Aug 7, 2020Aug 7, 2020 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
SALE
26,860$158.43$4.26M3,132,280Aug 7, 2020Aug 7, 2020 ↗View →
MDXG
MIMEDX GROUP, INC.
PURCHASEGRANT
Stock grant
38,135——3,338,135Aug 5, 2020Aug 6, 2020 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
SALE
25,327$141.12$3.57M3,163,813May 15, 2020May 15, 2020 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
SALE
4,673$142.05$663.8K3,159,140May 15, 2020May 15, 2020 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
2,075——3,189,140Feb 28, 2020Feb 28, 2020 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
3,685——3,685Feb 28, 2020Feb 28, 2020 ↗View →
Other insiders · SRPT
Loading peer insiders…
About this filer
CIK 0001562371
ROLE
Director
PRIMARY
SRPT
COMPANIES
3
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001562371DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback